Tricida Inc (NASDAQ:TCDA)

33.56
Delayed Data
As of 4:00pm ET
 +0.59 / +1.79%
Today’s Change
19.43
Today|||52-Week Range
44.30
-11.08%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$1.7B

Company Description

Tricida, Inc. is a pharmaceutical company, which focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. The company was founded by Gerrit Klaerner and Craig Jon Hawker in 2013 and is headquartered in South San Francisco, CA.

Contact Information

Tricida, Inc.
7000 Shoreline Court
South San Francisco California 94080
P:(415) 429-7800
Investor Relations:

Employees

Shareholders

Other institutional49.04%
Individual stakeholders49.02%
Mutual fund holders24.67%

Top Executives

There are no executives to display.